Sun Pharmaceutical Industries is currently trading at Rs. 1462.55, up by 9.30 points or 0.64% from its previous closing of Rs. 1453.25 on the BSE.

The scrip opened at Rs. 1450.40 and has touched a high and low of Rs. 1476.05 and Rs. 1444.20 respectively. So far 63800 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1638.70 on 05-Apr-2024 and a 52 week low of Rs. 977.50 on 23-Jun-2023.

Last one week high and low of the scrip stood at Rs. 1495.55 and Rs. 1440.20 respectively. The current market cap of the company is Rs. 352390.33 crore.

The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 36.54% and 8.97% respectively.

Sun Pharmaceutical Industries’ subsidiary -- Sun Pharmaceutical Industries Inc. is recalling 35,069 bottles of medication used to treat high pressure inside the eye due to glaucoma or other eye diseases. Sun Pharmaceutical Industries Inc is recalling the affected lot of Xelpros (latanoprost ophthalmic emulsion) due to ‘out of specification for particulate matter test’. The company initiated the voluntary Class III recall in the US on April 22 this year. 

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.